Middle tumor antigen. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy23

Cell Line, Tumor Ear, Middle T-Lymphocytes Cell Line T-Lymphocytes, Cytotoxic Dendritic Cells CD8-Positive T-Lymphocytes Cells, Cultured Middle Cerebral Artery CD4-Positive T-Lymphocytes Lymphocytes, Tumor-Infiltrating Clone Cells Antigen-Presenting Cells Spleen Tumor Cells, Cultured Lymph Nodes B-Lymphocytes Immune Sera Cell Line, Transformed Lymphocytes Hybridomas Macrophages Fibroblasts

Organisms15

Polyomavirus Simian virus 40 Mice, Inbred BALB C Mice, Inbred C57BL Mice, Transgenic Polyomaviridae Mice, SCID Mice, Nude Mice, Inbred Strains Adenoviridae Haplorhini Mice, Knockout Rabbits Oncogenic Viruses Adenoviruses, Human

Diseases41

Neoplasms, Experimental Neoplasms Melanoma, Experimental Wilms Tumor Mammary Neoplasms, Experimental Melanoma Cell Transformation, Neoplastic Brain Neoplasms Sarcoma, Experimental Fibrosarcoma Carcinoid Tumor Adenocarcinoma Cell Transformation, Viral Colonic Neoplasms Neuroendocrine Tumors Neoplasm Metastasis Ovarian Neoplasms Skin Neoplasms Neovascularization, Pathologic Kidney Neoplasms Infarction, Middle Cerebral Artery Liver Neoplasms Disease Models, Animal Gastrointestinal Stromal Tumors Breast Neoplasms Pancreatic Neoplasms Lymphoma Glioma Disease Progression Carcinoma, Squamous Cell Tumor Virus Infections Lung Neoplasms Carcinoma, Ehrlich Tumor Glioblastoma Carcinoma, Hepatocellular Hypersensitivity, Delayed Carcinoma, Renal Cell Rhabdoid Tumor Granulosa Cell Tumor Urinary Bladder Neoplasms Mammary Neoplasms, Animal

Chemicals and Drugs97

Antigens, Viral, Tumor Antigens, Polyomavirus Transforming Proto-Oncogene Proteins pp60(c-src)Antigens, Neoplasm Antigens Antigens, Bacterial Antigens, Surface Antigens, Viral Cancer Vaccines Tumor Markers, Biological Tumor Necrosis Factor-alpha Antibodies, Monoclonal HLA-A2 Antigen Carcinoembryonic Antigen Neoplasm Proteins HLA Antigens Epitopes Antigens, Protozoan MART-1 Antigen Tumor Suppressor Protein p53 Antigens, CD H-2 Antigens Antibodies, Neoplasm Antigens, Fungal gp100 Melanoma Antigen Antigens, Tumor-Associated, Carbohydrate Receptors, Antigen, T-Cell HLA-A Antigens Antigens, Helminth Melanoma-Specific Antigens HLA-DR Antigens Histocompatibility Antigens Class II Histocompatibility Antigens RNA, Messenger Histocompatibility Antigens Class I Interferon-gamma Proliferating Cell Nuclear Antigen Tumor Suppressor Proteins Immunoglobulin G Epitopes, T-Lymphocyte Prostate-Specific Antigen Mucin-1 Antigens, CD8 Receptors, Antigen, B-Cell Antigens, CD80 Antigens, CD3 O Antigens Peptide Fragments Peptides Recombinant Proteins Antigens, CD15 Receptors, Antigen Recombinant Fusion Proteins Antibodies Antigens, Differentiation Antigens, CD40 HLA-A1 Antigen DNA, Viral Ovalbumin Cytokines Immune Sera Hepatitis B Surface Antigens Membrane Proteins Blood Group Antigens DNA, Neoplasm Antigen-Antibody Complex Adjuvants, Immunologic Oncogene Proteins, Viral HLA-A3 Antigen Ki-67 Antigen Autoantigens Antigens, CD45 HLA-D Antigens Antigens, CD4 Vaccines, DNA Glycoproteins DNA-Binding Proteins Antigens, CD86 Hepatitis B Antigens Antigens, CD1 Interleukin-2 Membrane Glycoproteins DNA Antibodies, Bacterial DNA Primers Vaccines, Synthetic RNA, Neoplasm CTLA-4 Antigen Receptors, Antigen, T-Cell, alpha-beta HLA-B Antigens Antibodies, Anti-Idiotypic HLA-B7 Antigen Methylcholanthrene Autoantibodies HLA-A24 Antigen Viral Proteins WT1 Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment40

Neoplasms, Experimental Tumor Burden Immunotherapy Lymphocyte Activation Melanoma, Experimental Immunotherapy, Adoptive Enzyme-Linked Immunosorbent Assay Mammary Neoplasms, Experimental Sarcoma, Experimental Flow Cytometry Transfection Immunization Neoplasm Transplantation Fluorescent Antibody Technique Immunoenzyme Techniques Immunohistochemistry Transplantation, Heterologous Reverse Transcriptase Polymerase Chain Reaction Blotting, Western Disease Models, Animal Xenograft Model Antitumor Assays Immunotherapy, Active Sensitivity and Specificity Neoplasm Staging Polymerase Chain Reaction Vaccination Treatment Outcome Cloning, Molecular Cytotoxicity Tests, Immunologic Genetic Therapy Combined Modality Therapy Gene Expression Profiling Tomography, X-Ray Computed Immunoblotting Magnetic Resonance Imaging Leukocyte Adherence Inhibition Test Complement Fixation Tests Retrospective Studies Survival Analysis Electrophoresis, Polyacrylamide Gel

Phenomena and Processes44

Lymphocyte Activation Amino Acid Sequence Cytotoxicity, Immunologic Base Sequence Genes, Tumor Suppressor Transfection Tumor Microenvironment Antigen Presentation Antibody Specificity Cell Division Time Factors Cell Transformation, Viral Cell Proliferation Cross Reactions Mutation Immunity, Cellular Cross-Priming Antibody Formation Molecular Weight Genetic Vectors Antigen-Antibody Reactions Signal Transduction Phenotype Gene Expression Gene Expression Regulation, Neoplastic Sensitivity and Specificity Immune Tolerance Protein Binding Tumor Escape Tissue Distribution Cell Survival Cell Differentiation Plasmids Cell Movement Transcription, Genetic Promoter Regions, Genetic Gene Expression Regulation Apoptosis Major Histocompatibility Complex DNA Replication Dose-Response Relationship, Drug Up-Regulation Genes, Viral Down-Regulation

Disciplines and Occupations1

Immunohistochemistry

Information Science3

Molecular Sequence Data Amino Acid Sequence Base Sequence

Health Care6

Immunization Sensitivity and Specificity Vaccination Treatment Outcome Retrospective Studies Survival Analysis

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Polyomavirus Antigens, Viral, Tumor Antigens, Polyomavirus Transforming Proto-Oncogene Proteins pp60(c-src)Antigens, Neoplasm Antigens Antigens, Bacterial Antigens, Surface Antigens, Viral Cancer Vaccines Simian virus 40 Cell Line, Tumor Tumor Markers, Biological Neoplasms, Experimental Ear, Middle Mice, Inbred BALB C Tumor Necrosis Factor-alpha Antibodies, Monoclonal Tumor Burden HLA-A2 Antigen Carcinoembryonic Antigen Immunotherapy Neoplasm Proteins Mice, Inbred C57BL HLA Antigens T-Lymphocytes Cell Line T-Lymphocytes, Cytotoxic Molecular Sequence Data Epitopes Dendritic Cells Antigens, Protozoan Neoplasms MART-1 Antigen Tumor Suppressor Protein p53 Antigens, CD H-2 Antigens Lymphocyte Activation Melanoma, Experimental Antibodies, Neoplasm CD8-Positive T-Lymphocytes Amino Acid Sequence Wilms Tumor Antigens, Fungal gp100 Melanoma Antigen Antigens, Tumor-Associated, Carbohydrate Cytotoxicity, Immunologic Receptors, Antigen, T-Cell HLA-A Antigens Mice, Transgenic Antigens, Helminth Immunotherapy, Adoptive Enzyme-Linked Immunosorbent Assay Base Sequence Melanoma-Specific Antigens Genes, Tumor Suppressor HLA-DR Antigens Polyomaviridae Mammary Neoplasms, Experimental Melanoma Cell Transformation, Neoplastic Brain Neoplasms Sarcoma, Experimental Histocompatibility Antigens Class II Fibrosarcoma Carcinoid Tumor Histocompatibility Antigens RNA, Messenger Flow Cytometry Histocompatibility Antigens Class I Adenocarcinoma Transfection Tumor Microenvironment Antigen Presentation Immunization Cells, Cultured Antibody Specificity Interferon-gamma Cell Division Time Factors Proliferating Cell Nuclear Antigen Cell Transformation, Viral Colonic Neoplasms Neoplasm Transplantation Neuroendocrine Tumors Middle Cerebral Artery Cell Proliferation Tumor Suppressor Proteins Neoplasm Metastasis Cross Reactions Immunoglobulin G Epitopes, T-Lymphocyte Mutation CD4-Positive T-Lymphocytes Fluorescent Antibody Technique Lymphocytes, Tumor-Infiltrating Immunoenzyme Techniques Immunohistochemistry Immunity, Cellular Ovarian Neoplasms

No FAQ available that match "middle tumor antigen"